Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

CVRX

CVRx (CVRX)

CVRx Inc
Da:
Ordina per:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CVRX
DataOraFonteTitoloSimboloCompagnia
04/03/202522:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CVRXCVRx Inc
18/02/202513:56Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CVRXCVRx Inc
18/02/202513:40Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CVRXCVRx Inc
14/02/202523:10Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CVRXCVRx Inc
12/02/202520:45GlobeNewswire Inc.CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with BarostimNASDAQ:CVRXCVRx Inc
07/02/202500:49Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:CVRXCVRx Inc
06/02/202522:46Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CVRXCVRx Inc
04/02/202522:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CVRXCVRx Inc
04/02/202522:05GlobeNewswire Inc.CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating ResultsNASDAQ:CVRXCVRx Inc
21/01/202522:30GlobeNewswire Inc.CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025NASDAQ:CVRXCVRx Inc
13/01/202514:00GlobeNewswire Inc.CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2024 Financial Results and Issues Fiscal 2025 GuidanceNASDAQ:CVRXCVRx Inc
23/12/202422:30GlobeNewswire Inc.CVRx to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:CVRXCVRx Inc
29/11/202420:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CVRXCVRx Inc
20/11/202422:30GlobeNewswire Inc.CVRx to Present at the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:CVRXCVRx Inc
04/11/202414:00GlobeNewswire Inc.CVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025NASDAQ:CVRXCVRx Inc
01/11/202411:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CVRXCVRx Inc
29/10/202421:05GlobeNewswire Inc.CVRx Reports Third Quarter 2024 Financial and Operating ResultsNASDAQ:CVRXCVRx Inc
18/10/202420:08GlobeNewswire Inc.CVRx announces new CPT® Category I codes for BarostimNASDAQ:CVRXCVRx Inc
15/10/202422:30GlobeNewswire Inc.CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024NASDAQ:CVRXCVRx Inc
12/09/202414:00GlobeNewswire Inc.CVRx announces new publication reinforcing the long-term quality of life benefits of BarostimNASDAQ:CVRXCVRx Inc
03/09/202414:30GlobeNewswire Inc.CVRx Announces Appointment of Two New Board MembersNASDAQ:CVRXCVRx Inc
05/08/202423:20PR Newswire (US)CVRx, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CVRXNASDAQ:CVRXCVRx Inc
02/08/202414:00GlobeNewswire Inc.CVRx Announces Increased Inpatient Payment for Barostim ProcedureNASDAQ:CVRXCVRx Inc
31/07/202422:27GlobeNewswire Inc.CVRx to Present at the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:CVRXCVRx Inc
29/07/202422:05GlobeNewswire Inc.CVRx Reports Second Quarter 2024 Financial and Operating ResultsNASDAQ:CVRXCVRx Inc
15/07/202422:30GlobeNewswire Inc.CVRx to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call on July 29th, 2024NASDAQ:CVRXCVRx Inc
25/06/202412:50GlobeNewswire Inc.CVRx Announces Appointment of Robert Allen John as Chief Revenue OfficerNASDAQ:CVRXCVRx Inc
07/06/202423:25Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:CVRXCVRx Inc
22/05/202414:30GlobeNewswire Inc.CVRx to Present at the William Blair 44th Annual Growth Stock ConferenceNASDAQ:CVRXCVRx Inc
16/05/202422:15Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:CVRXCVRx Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CVRX